Initial reaction is we are getting shorted 1:5. Upon further thought though I kinda like this. Less dilution to gnbt and additional stake in NGIO (which as a potential M&A target could = $$$)
What is not clear is if the remaining restricted shares are eligible. It SEEMS like they are not but no mention of it is hmm, interesting.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links